Skip to main content

Advertisement

SpringerLink
Log in

Surgical treatment for nasal polyposis: predictors of outcome

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Nasal polyps recur in approximately one-third of patients after surgical treatment. It would be beneficial to be able to predict the patients in whom we might expect recurrence and to predict the clinical outcome after surgery. The study included 30 patients operated for nasal polyps. Removed polyps were analyzed by immunohistochemical analysis for IL-5, IgE, vascular endothelial growth factor and eosinophilic infiltration. These parameters together with preoperative CT score were used as independent variables, and subjective score improvement after 2 years was used as a dependent variable in multiple linear regression analysis. Furthermore, the patients were divided into two groups: low and high polyp tissue immunoreactivity. The Chi-squared test was used to determine whether polyp immunoreactivity influences polyp recurrence and subjective score. Preoperative CT score had a slightly positive correlation with subjective score after 2 years. High eosinophil infiltration significantly predicted a higher risk for polyp recurrence. High IL-5 positivity was related to greater risk for polyp recurrence than low IL-5 reactivity but not significantly. IgE and VEGF reactivity in polyp specimens did not have any effect on polyp recurrence. High eosinophilic infiltration in polyps can predict worse outcome after surgical treatment of chronic rhinosinusitis with nasal polyposis. IgE and VEGF do not have prognostic significance to polyp recurrence after surgery. The preoperative extent of disease measured by CT score had a slightly positive correlation with worse outcome after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Fokkens WJ, Lund VJ, Mullol J et al (2012) European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 50(Suppl. 23):1–298

    PubMed  Google Scholar 

  2. Larsen PL, Toš M (1997) Origin and structure of nasal polyps. In: Mygind N, Lildholdt T (eds) Nasal polyposis: an inflammatory disease and its treatment. Munksgaard, Copenhagen, pp 20–28

    Google Scholar 

  3. Settipane GA (1987) Nasal polyps: epidemiology, pathology, immunology and treatment. Am J Rhinol 1:119–126

    Article  Google Scholar 

  4. Shatkin JS, Delsupehe KG, Thisted RA, Corey JP (1994) Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis; a meta analysis. Otolaryngol Head Neck Surg 111:553–556

    Article  CAS  PubMed  Google Scholar 

  5. Bachert C, Gevaert P, Holtappels G et al (2001) Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107:607–610

    Article  CAS  PubMed  Google Scholar 

  6. Hirschberg A, Jokuti A, Darvas Z et al (2003) The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Laryngoscope 113:120–124

    Article  CAS  PubMed  Google Scholar 

  7. Xu R, Li Y, Xie M et al (2002) Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues. Chin Med J 115:1386–1389

    CAS  PubMed  Google Scholar 

  8. Wang JH, Kwon HJ, Jang YJ (2010) Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy 24(6):422–427

    Article  PubMed  Google Scholar 

  9. Seiberling KA, Conley DB, Tripathi A et al (2005) Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 115:1580–1585

    Article  PubMed  Google Scholar 

  10. Bucholtz GA, Salzman SA, Bersalona FB et al (2002) PCR analysis of nasal polyps, chronic sinusitis, and hypertrophied turbinates for DNA encoding bacterial 16S rRNA. Am J Rhinol 16:169–173

    PubMed  Google Scholar 

  11. Wittekindt C, Hess A, Bloch W et al (2002) Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294–298

    PubMed  Google Scholar 

  12. Sun D, Matsune S, Ohori J, Fukuiwa T, Ushikai M, Kurono Y (2005) TNF-alpha and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 32:243–249

    Article  PubMed  Google Scholar 

  13. Hu KH, Lee FP, Cheng YJ, Huang HM (2007) Vascular endothelial growth factor and children featuring nasal polyps. Int J Pediatr Otorhinolaryngol 71:23–28

    Article  PubMed  Google Scholar 

  14. Nakayama T, Yoshikawa M, Asaka D et al (2011) Mucosal eosinophilia and recurrence of nasal polyps—new classification of chronic rhinosinusitis. Rhinology 49(4):392–396

    CAS  PubMed  Google Scholar 

  15. Alobid I, Benitez P, Bernal-Sprekelson M, Guilemany JM, Picado C, Mullol J (2005) The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 14:789–793

    Article  PubMed  Google Scholar 

  16. Punekar YS, Ahmad A, Saleh HA (2011) Estimating the effect of nasal steroid treatment on repeat polypectomies: survival time analysis using the General Practice Research Database. Rhinology 49:190–194

    CAS  PubMed  Google Scholar 

  17. Baudoin T, Čupić H, Geber G et al (2006) Histopathologic parameters as predictors of response to endoscopic sinus surgery in nonallergic patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 134:761–766

    Article  PubMed  Google Scholar 

  18. Baudoin T, Kalogjera L, Geber G et al (2008) Correlation of histopathology and symptoms in allergic and non-allergic patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 265:657–661

    Article  PubMed  Google Scholar 

  19. Terwee CB, Bot SD, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42

    Article  PubMed  Google Scholar 

  20. Lund VJ, Kennedy DW (1995) Quantification for staging sinusitis. The staging and therapy group. Ann Otol Rhinol Laryngol Suppl 167:17–21

    CAS  PubMed  Google Scholar 

  21. Lund VJ, Mackay IS (1993) Staging in rhinosinusitis. Rhinology 31:183–184

    CAS  PubMed  Google Scholar 

  22. Kalogjera L, Glumbić I, Zurak K et al (1998) Correlation between eosinophil infiltration and hyperreactive response to distilled water challenge in chronic rhinosinusitis. Acta Clin Croat 37:197–201

    Google Scholar 

  23. Frączek M, Rostkowska-Nadolska B, Kapral M, Szota J, Kręcicki T, Mazurek U (2013) Microarray analysis of NF-κB-dependent genes in chronic rhinosinusitis with nasal polyps. Adv Clin Exp Med 22(2):209–217

    PubMed  Google Scholar 

  24. Akdis CA, Bachert C, Cingi C et al (2013) Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 131:1979–1990

    Article  Google Scholar 

  25. Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S (2013) Chronic rhinosinusitis and emerging treatment options. Int J Gen Med 6:453–464

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Gevaert P, Van Bruaene N, Cattaert T et al (2011) Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128(5):989–995

    Article  CAS  PubMed  Google Scholar 

  27. Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM (2010) A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology 48(3):318–324

    CAS  PubMed  Google Scholar 

  28. Drviš P, Kalogjera L, Baudoin T (2003) Prognostic value of IL-5 in sinus lavage in patients with chronic maxillary sinusitis. Acta Clin Croat 42:315–319

    Google Scholar 

  29. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS (2005) Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 43(1):2–10

    PubMed  Google Scholar 

  30. Soler ZM, Sauer D, Mace J, Smith TL (2010) Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery. Otolaryngol Head Neck Surg 142(1):64–71

    Article  PubMed Central  PubMed  Google Scholar 

  31. Kim DW, Kim JY, Jeon SY (2011) The status of the olfactory cleft may predict postoperative olfactory function in chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy 25(2):90–94

    Article  Google Scholar 

  32. Wu AW, Ting JY, Platt MP, Tierney HS, Metson R (2013) Factors affecting time to revision sinus surgery for nasal polyps: A 25-year experience. Laryngoscope. doi:10.1002/lary.24213 (Epub ahead of print)

    PubMed Central  Google Scholar 

  33. Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J (2009) Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope 119(12):2459–2465

    Article  PubMed  Google Scholar 

  34. Payne SC, Early SB, Huyett P, Han JK, Borish L, Steinke JW (2011) Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope 121(10):2262–2267

    Article  PubMed Central  PubMed  Google Scholar 

  35. Eweiss AZ, Lund VJ, Barlow J (2013) Do patients with chronic rhinosinusitis with nasal polyps suffer with facial pain? Rhinology 51:231–235

    CAS  PubMed  Google Scholar 

  36. Van Zele T, Holtappels G, Gevaert P, Bachert C (2014) Differences in initial immunoprofiles between recurrent and nonrecurrent chronic sinusitis with nasal polyps. Am J Rhinol Allergy 28(3):192–198

    Article  PubMed  Google Scholar 

  37. Fruth K, Zhu C, Schramek E, Angermair J, Kassem W, Haxel BR, Schneider A, Mann WJ, Brieger J (2012) Vascular endothelial growth factor expression in nasal polyps of aspirin-intolerant patients. Arch Otolaryngol Head Neck Surg 138(3):286–293

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of ENT and Head and Neck Surgery, ‘Sisters of Mercy’ University Medical Center, Zagreb University School of Medicine, Vinogradska 29, Zagreb, Croatia

    Marko Velimir Grgić, Livije Kalogjera & Tomislav Baudoin

  2. Department of Pathology, University Hospital ‘Sisters of Mercy’ University Medical Center, Zagreb University School of Dentistry, Vinogradska 29, Zagreb, Croatia

    Hrvoje Ćupić

Authors
  1. Marko Velimir Grgić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hrvoje Ćupić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Livije Kalogjera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomislav Baudoin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marko Velimir Grgić.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grgić, M.V., Ćupić, H., Kalogjera, L. et al. Surgical treatment for nasal polyposis: predictors of outcome. Eur Arch Otorhinolaryngol 272, 3735–3743 (2015). https://doi.org/10.1007/s00405-015-3519-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-015-3519-7

Keywords

Search

Navigation